SRZN · Company research
Surrozen, Inc. Common (SRZN): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
18records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Surrozen (SRZN) Jumps 5.56% to $25.07 as Biotech Name Tests Upper Range - MA Crossover - https://www.siam.in/ | Surrozen (SRZN) Jumps 5.56% to $25.07 as Biotech Name Tests Upper Range - MA Crossover https://www.siam.in/ | View source ↗ | https://www.siam.in/ | Oct 16, 2026 | neutral | 0 | 0.6 |
| Understanding the Setup: (SRZN) and Scalable Risk - Stock Traders Daily | Understanding the Setup: (SRZN) and Scalable Risk Stock Traders Daily | View source ↗ | Stock Traders Daily | Oct 15, 2026 | neutral | 0 | 0.6 |
| Surrozen (SRZN) Stock Screener: -5.05% Decline on Elevated Volume 2026-10-14 - Volatility Smirk - https://www.dars.gov.et/ | Surrozen (SRZN) Stock Screener: -5.05% Decline on Elevated Volume 2026-10-14 - Volatility Smirk https://www.dars.gov.et/ | View source ↗ | https://www.dars.gov.et/ | Oct 14, 2026 | neutral | 0 | 0.6 |
| $SRZN stock is down 19% today. Here's what we see in our data. - Quiver Quantitative | $SRZN stock is down 19% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | Oct 12, 2026 | neutral | 0 | 0.6 |
| $SRZN stock is down 19% today. Here's what we see in our data. - Quiver Quantitative | $SRZN stock is down 19% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | Oct 12, 2026 | neutral | 0 | 0.6 |
| Surrozen (SRZN) Stock Forecast: Can +11.23% Upside Continue? 2026-10-09 - PCR Spike - https://www.dars.gov.et/ | Surrozen (SRZN) Stock Forecast: Can +11.23% Upside Continue? 2026-10-09 - PCR Spike https://www.dars.gov.et/ | View source ↗ | https://www.dars.gov.et/ | Oct 9, 2026 | neutral | 0 | 0.6 |
| Surrozen, Inc. Common Stock (SRZN) Stock Price: Oct 7 Close $25.15 - Gotrade | Surrozen, Inc. Common Stock (SRZN) Stock Price: Oct 7 Close $25.15 Gotrade | View source ↗ | Gotrade | Oct 8, 2026 | neutral | 0 | 0.6 |
| Four parties report the same 1.36M-share stake in Surrozen (SRZN). - Stock Titan | Four parties report the same 1.36M-share stake in Surrozen (SRZN). Stock Titan | View source ↗ | Stock Titan | Oct 7, 2026 | neutral | 0 | 0.6 |
| Surrozen Wins FDA IND Clearance for SZN-8141 Program - The Globe and Mail | Surrozen Wins FDA IND Clearance for SZN-8141 Program The Globe and Mail | View source ↗ | The Globe and Mail | Oct 3, 2026 | neutral | 0 | 0.6 |
| About $95.1 million is expected from Surrozen’s financing after FDA cleared its eye-study application. - Stock Titan | About $95.1 million is expected from Surrozen’s financing after FDA cleared its eye-study application. Stock Titan | View source ↗ | Stock Titan | Oct 2, 2026 | neutral | 0 | 0.6 |
| Surrozen (SRZN) Slips 6.63% to $30.05, Retreating Toward Support at $28.55 - Growth Factor - siam.in | Surrozen (SRZN) Slips 6.63% to $30.05, Retreating Toward Support at $28.55 - Growth Factor siam.in | View source ↗ | siam.in | Oct 1, 2026 | neutral | 0 | 0.6 |
| 12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga | 12 Health Care Stocks Moving In Thursday's Pre-Market Session Benzinga | View source ↗ | Benzinga | Sep 24, 2026 | neutral | 0 | 0.6 |
| Surrozen (SRZN) stock doubles as traders focus on IND progress and potential financing milestone - Quiver Quantitative | Surrozen (SRZN) stock doubles as traders focus on IND progress and potential financing milestone Quiver Quantitative | View source ↗ | Quiver Quantitative | Sep 24, 2026 | neutral | 0 | 0.6 |
| Which stocks are moving on Thursday? - ChartMill | Which stocks are moving on Thursday? ChartMill | View source ↗ | ChartMill | Sep 24, 2026 | neutral | 0 | 0.6 |
| One drug combines two approaches for diabetic vision loss. Surrozen submitted an application to the FDA. - Stock Titan | One drug combines two approaches for diabetic vision loss. Surrozen submitted an application to the FDA. Stock Titan | View source ↗ | Stock Titan | Sep 8, 2026 | neutral | 0 | 0.6 |
| Analysts Just Made A Massive Upgrade To Their Surrozen, Inc. (NASDAQ:SRZN) Forecasts - Simply Wall Street | Analysts Just Made A Massive Upgrade To Their Surrozen, Inc. (NASDAQ:SRZN) Forecasts Simply Wall Street | View source ↗ | Simply Wall Street | Aug 13, 2026 | neutral | 0 | 0.6 |
| Surrozen (SRZN) Stock Price Jumps Despite Deepening Losses And Rich Valuation - Simply Wall Street | Surrozen (SRZN) Stock Price Jumps Despite Deepening Losses And Rich Valuation Simply Wall Street | View source ↗ | Simply Wall Street | Aug 8, 2026 | neutral | 0 | 0.6 |
| Surrozen (SRZN) Surges 5.9%: Is This an Indication of Further Gains? - Yahoo Finance | Surrozen (SRZN) Surges 5.9%: Is This an Indication of Further Gains? Yahoo Finance | View source ↗ | Yahoo Finance | Apr 14, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.